Email ID
Password
Scrip   
How Wyeth will change Pfizer's R&D focus
29 April 2009
Peter Charlish

Pfizer’s proposed $68 billion acquisition of Wyeth will accelerate the shift in focus of its R&D portfolio, according to the results of a recent analysis of the two companies’ clinical trials programmes. Pfizer confirmed last year, before the acquisition was announced, that it was...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36